Omeros (OMER) Cash from Operations (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 63.59% |
| Dec 31, 2025 | -115.92% |
| Sep 30, 2025 | 15.97% |
| Jun 30, 2025 | 38.73% |
| Mar 31, 2025 | -23.67% |
| Dec 31, 2024 | 9.60% |
| Sep 30, 2024 | 30.29% |
| Jun 30, 2024 | -10.06% |
| Mar 31, 2024 | -19.97% |
| Dec 31, 2023 | -6.67% |
| Sep 30, 2023 | -0.95% |
| Jun 30, 2023 | -118.53% |
| Mar 31, 2023 | 787.65% |
| Dec 31, 2022 | 4.00% |
| Sep 30, 2022 | -35.80% |
| Jun 30, 2022 | -28.14% |
| Mar 31, 2022 | 16.59% |
| Dec 31, 2021 | 23.02% |
| Sep 30, 2021 | 14.25% |
| Jun 30, 2021 | 31.46% |
| Mar 31, 2021 | -118.69% |
| Dec 31, 2020 | 47.32% |
| Sep 30, 2020 | 7.06% |
| Jun 30, 2020 | -311.30% |
| Mar 31, 2020 | 60.28% |
| Dec 31, 2019 | -205.96% |
| Sep 30, 2019 | 54.66% |
| Jun 30, 2019 | -28.12% |
| Mar 31, 2019 | 47.49% |
| Dec 31, 2018 | 33.13% |
| Sep 30, 2018 | -19.29% |
| Jun 30, 2018 | -173.64% |
| Mar 31, 2018 | -170.76% |
| Dec 31, 2017 | 62.73% |
| Sep 30, 2017 | -37.20% |
| Jun 30, 2017 | 35.77% |
| Mar 31, 2017 | -16.93% |
| Dec 31, 2016 | 3.16% |
| Sep 30, 2016 | 12.33% |
| Jun 30, 2016 | 23.05% |
| Mar 31, 2016 | -0.17% |
| Dec 31, 2015 | -13.79% |
| Sep 30, 2015 | 11.83% |
| Jun 30, 2015 | 5.33% |
| Mar 31, 2015 | -11.38% |
| Dec 31, 2014 | 1.57% |
| Sep 30, 2014 | -4.39% |
| Jun 30, 2014 | -37.10% |
| Mar 31, 2014 | -3,663.18% |
| Dec 31, 2013 | 97.32% |
| Sep 30, 2013 | -17.51% |
| Jun 30, 2013 | -4.74% |
| Mar 31, 2013 | 29.85% |
| Dec 31, 2012 | -72.73% |
| Sep 30, 2012 | 16.48% |
| Jun 30, 2012 | -60.96% |
| Mar 31, 2012 | 25.21% |
| Dec 31, 2011 | -79.23% |
| Sep 30, 2011 | 35.07% |
| Jun 30, 2011 | 19.68% |
| Mar 31, 2011 | -218.92% |
| Dec 31, 2010 | 212.28% |